[go: up one dir, main page]

MXPA05011677A - Benzofuranil y benzotienil-piperacinil quinolinas como inhibidores de la reabsorcion de serotonina. - Google Patents

Benzofuranil y benzotienil-piperacinil quinolinas como inhibidores de la reabsorcion de serotonina.

Info

Publication number
MXPA05011677A
MXPA05011677A MXPA05011677A MXPA05011677A MXPA05011677A MX PA05011677 A MXPA05011677 A MX PA05011677A MX PA05011677 A MXPA05011677 A MX PA05011677A MX PA05011677 A MXPA05011677 A MX PA05011677A MX PA05011677 A MXPA05011677 A MX PA05011677A
Authority
MX
Mexico
Prior art keywords
benzothienyl
benzofuranyl
quinolines
piperazinyl
serotonin reuptake
Prior art date
Application number
MXPA05011677A
Other languages
English (en)
Inventor
Richard Eric Mewshaw
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of MXPA05011677A publication Critical patent/MXPA05011677A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen derivados de benzofuranil y benzotienil-piperacinil quinolina y composiciones que contienen esos compuestos. Tambien se describen metodos de uso de derivados de benzofuranil y benzotienil-piperacinil quinolina y composiciones que contienen esos compuestos en el tratamiento y/o prevencion de trastornos relacionados con la serotonina, como la depresion y ansiedad. Ademas, se describen procesos para la preparacion de derivados de benzofuranil y benzotienil-piperacinil quinolina (ver formula (I)).
MXPA05011677A 2003-05-02 2004-04-30 Benzofuranil y benzotienil-piperacinil quinolinas como inhibidores de la reabsorcion de serotonina. MXPA05011677A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46736803P 2003-05-02 2003-05-02
US10/835,185 US7276603B2 (en) 2003-05-02 2004-04-29 Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use
PCT/US2004/013350 WO2004099191A2 (en) 2003-05-02 2004-04-30 Benzofuranyl-and benzothienyl-piperazinyl quinolines as serotonin reuptake inhib itors

Publications (1)

Publication Number Publication Date
MXPA05011677A true MXPA05011677A (es) 2005-12-15

Family

ID=33436728

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011677A MXPA05011677A (es) 2003-05-02 2004-04-30 Benzofuranil y benzotienil-piperacinil quinolinas como inhibidores de la reabsorcion de serotonina.

Country Status (8)

Country Link
US (1) US7276603B2 (es)
EP (1) EP1641785A2 (es)
JP (1) JP2006525348A (es)
AU (1) AU2004236215A1 (es)
BR (1) BRPI0409958A (es)
CA (1) CA2524324A1 (es)
MX (1) MXPA05011677A (es)
WO (1) WO2004099191A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7390670B2 (en) * 2003-02-20 2008-06-24 Lumigen, Inc. Signalling compounds and methods for detecting hydrogen peroxide
KR100659498B1 (ko) * 2005-03-10 2006-12-20 애니젠 주식회사 벤조퓨로인돌계 칼륨 채널 개시제
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
BRPI0710329A2 (pt) * 2006-05-05 2011-08-09 Dow Global Technologies Inc complexo metálico, processo para a preparação de um complexo de háfnio, processo de polimerização por adição, processo para a bromação seletiva, processo para preparar um éster borato de benzofuran-3-ila 2- substituìdo estável e processo para preparar um 2-formilimidazol
TW200808730A (en) * 2006-06-09 2008-02-16 Wyeth Corp Process for synthesizing piperazine-piperidine compounds
TW200846032A (en) * 2007-02-16 2008-12-01 Wyeth Corp Sustained-release tablet formulations of piperazine-piperidine antagonists and agonists of the 5-HT1A receptor having enhanced intestinal dissolution
CN101619056B (zh) * 2008-07-02 2013-07-17 石药集团中奇制药技术（石家庄）有限公司 苯并噻吩烷醇哌嗪衍生物及其作为抗抑郁症药物的应用
WO2015014256A1 (en) 2013-07-29 2015-02-05 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof
WO2016192657A1 (en) 2015-06-03 2016-12-08 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof
EP3870292A4 (en) 2018-10-26 2022-11-09 The Research Foundation for The State University of New York COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA
AU2022328217A1 (en) * 2021-08-12 2024-03-14 Kuleon Llc Hallucinogenic and non-hallucinogenic serotonin receptor agonists and methods of making and using the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830312D0 (en) 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
ZA929008B (en) 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
US5468768A (en) 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
EP1070063A1 (en) 1998-04-08 2001-01-24 American Home Products Corporation Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)
TW520367B (en) 1998-04-29 2003-02-11 Wyeth Corp Indolyl derivatives as serotonergic agents
JP2003521443A (ja) 1998-06-19 2003-07-15 ハー・ルンドベック・アクチエゼルスカベット ４，５，６及び７−インドール及びインドリン誘導体、その製造方法及びその使用方法
AR021509A1 (es) 1998-12-08 2002-07-24 Lundbeck & Co As H Derivados de benzofurano, su preparacion y uso
US6313126B1 (en) * 1999-01-07 2001-11-06 American Home Products Corp Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
HUP0200309A3 (en) 1999-01-07 2003-05-28 Wyeth Corp Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression, process for their preparation and pharmaceutical compositions containing them
AR022303A1 (es) 1999-01-22 2002-09-04 Lundbeck & Co As H Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion
ES2244469T3 (es) 1999-08-23 2005-12-16 Solvay Pharmaceuticals B.V. Fenilpiperazinas como inhibidores de la recaptacion de serotonina.
FR2799463B1 (fr) 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
ES2188344B1 (es) 2000-11-29 2004-09-16 Laboratorios Vita, S.A. Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.

Also Published As

Publication number Publication date
US7276603B2 (en) 2007-10-02
JP2006525348A (ja) 2006-11-09
BRPI0409958A (pt) 2006-04-25
WO2004099191A3 (en) 2005-02-10
AU2004236215A1 (en) 2004-11-18
WO2004099191A2 (en) 2004-11-18
EP1641785A2 (en) 2006-04-05
US20050059673A1 (en) 2005-03-17
CA2524324A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
TW200503705A (en) 3-amino chroman and 2-amino tetralin derivatives
TW200510416A (en) P38 inhibitors and methods of use thereof
MX2009005455A (es) (r)-n-estereoisomeros de analogos de 7,8-saturados-4,5 epoxi-morfinano.
TW200612892A (en) Novel compounds
WO2005004818A3 (en) Heterocyclic compounds and their use as anticancer agents
IL196543A (en) Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders
WO2006107451A3 (en) Honokiol derivatives for the treatment of proliferative disorders
WO2004078116A3 (en) P38 inhibitors and methods of use thereof
WO2007064797A3 (en) Inhibitors of c-met and uses thereof
TW200633980A (en) Pyridones useful as inhibitors of kinases
TW200505837A (en) Novel compounds
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
TW200519075A (en) Novel compounds
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
MXPA05012680A (es) Indoles novedosos de 3-azufre sustituidos.
PT1730146E (pt) Azaindoles úteis como inibidores de jak e outras proteínas quinases
WO2006086562A3 (en) Phenylazetidinone derivatives
WO2006037024A3 (en) Salts of decitabine
WO2006034154A3 (en) Salts of 5-azacytidine
TW200732296A (en) Novel compounds
TW200510367A (en) Novel lapachone compounds, their preparation, and the use thereof
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
MXPA05011677A (es) Benzofuranil y benzotienil-piperacinil quinolinas como inhibidores de la reabsorcion de serotonina.
GB0320320D0 (en) Novel compounds

Legal Events

Date Code Title Description
FG Grant or registration